Select language:  
1800 620 420
Close menu

The Trials Enabling Program (TEP)

In an Australian first, we’ve established the Trials Enabling Program (TEP) that will help people with blood cancer access promising new drugs through international clinical trials.

In 2015, the Leukaemia Foundation set out to address the lack of international clinical trial presence in Australia. We partnered with the nation’s leading blood cancer clinical trial group – the Australasian Leukaemia & Lymphoma Group (ALLG) – to establish TEP.

TEP is a mechanism that improves access of patients in Australia to the latest ground-breaking research and new therapies by bringing international clinical trials to Australia. TEP will deliver new therapeutic drugs to patients years ahead of the expected availability on the Australian market.

This innovative program is the first time an Australian charity has established a grant partnership to help patients access international blood cancer trials.

Trials Enabling Program: FAQs

Trials Enabling Program FAQs
Illustration of various treatments, pills, medicines

Clinical trial for primary myelofibrosis

Assoc Prof Nada Hamad

Clinical trial for Advanced Stage Hodgkin Lymphoma

Professor Mark Hertzberg

Clinical trial for high tumour burden follicular lymphoma

Judith Trotman

Clinical trial for newly diagnosed AML or MDS with IDH1 or IDH2 mutation

Assoc. Prof. Paula Marlton

Clinical trial for newly diagnosed AML or MDS with FLT3 mutation

Andrew Wei standing in a laboratory

Last updated on January 30th, 2023

Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.